Moatar, A.I.; Chis, A.R.; Nitusca, D.; Oancea, C.; Marian, C.; Sirbu, I.-O.
HB-EGF Plasmatic Level Contributes to the Development of Early Risk Prediction Nomogram for Severe COVID-19 Cases. Biomedicines 2024, 12, 373.
https://doi.org/10.3390/biomedicines12020373
AMA Style
Moatar AI, Chis AR, Nitusca D, Oancea C, Marian C, Sirbu I-O.
HB-EGF Plasmatic Level Contributes to the Development of Early Risk Prediction Nomogram for Severe COVID-19 Cases. Biomedicines. 2024; 12(2):373.
https://doi.org/10.3390/biomedicines12020373
Chicago/Turabian Style
Moatar, Alexandra Ioana, Aimee Rodica Chis, Diana Nitusca, Cristian Oancea, Catalin Marian, and Ioan-Ovidiu Sirbu.
2024. "HB-EGF Plasmatic Level Contributes to the Development of Early Risk Prediction Nomogram for Severe COVID-19 Cases" Biomedicines 12, no. 2: 373.
https://doi.org/10.3390/biomedicines12020373
APA Style
Moatar, A. I., Chis, A. R., Nitusca, D., Oancea, C., Marian, C., & Sirbu, I.-O.
(2024). HB-EGF Plasmatic Level Contributes to the Development of Early Risk Prediction Nomogram for Severe COVID-19 Cases. Biomedicines, 12(2), 373.
https://doi.org/10.3390/biomedicines12020373